Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Soundship is an early-stage biotechnology company focused on developing ultrasound-mediated drug delivery systems. The company's technology aims to enhance the precision and efficacy of therapeutic delivery by using acoustic energy to trigger the release of drugs at specific anatomical sites. Founded by industry veterans with extensive experience in nucleic acid therapeutics, Soundship seeks to overcome traditional delivery barriers for complex modalities such as RNA. The company is currently in the pre-clinical stage, focusing on optimizing its acoustic-sensitive carrier technology to improve safety and efficacy profiles. Soundship is headquartered in Lexington, Massachusetts, and operates within the Boston-area life sciences ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Soundship.